Kristian Bjøro

  • Professor, Senior Consultant; MD, PhD
  • +47 23 07 07 17
 

Original articles

Dalgard O, Martinot-Peignoux M, Verbaan H, Bjøro K, Ring-Larsen H, Marcellin P (2015)
The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection
PLoS One, 10 (8), e0120866
DOI 10.1371/journal.pone.0120866, PubMed 26317978

Fosby B, Melum E, Bjøro K, Bennet W, Rasmussen A, Andersen IM, Castedal M, Olausson M, Wibeck C, Gotlieb M, Gjertsen H, Toivonen L, Foss S, Makisalo H, Nordin A, Sanengen T, Bergquist A, Larsson ME, Soderdahl G, Nowak G, Boberg KM, Isoniemi H, Keiding S, Foss A, Line PD et al. (2015)
Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013
Scand J Gastroenterol, 50 (6), 797-808
DOI 10.3109/00365521.2015.1036359, PubMed 25959101

Eskesen AN, Bjøro K, Aandahl EM, Line PD, Melum E (2014)
Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway--a population-based cohort study
Cancer Epidemiol, 38 (6), 741-7
DOI 10.1016/j.canep.2014.10.005, PubMed 25454262

Eskesen AN, Melum E, Moghaddam A, Bjøro K, Verbaan H, Ring-Larsen H, Dalgard O (2012)
Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort
Eur J Gastroenterol Hepatol, 24 (8), 890-6
DOI 10.1097/MEG.0b013e3283546efd, PubMed 22584257

Moghaddam A, Melum E, Reinton N, Ring-Larsen H, Verbaan H, Bjøro K, Dalgard O (2011)
IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
Hepatology, 53 (3), 746-54
DOI 10.1002/hep.24154, PubMed 21374656

Dalgard O, Bjoro K, Ring-Larsen H, Verbaan H (2010)
In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials
Eur J Gastroenterol Hepatol, 22 (5), 552-6
DOI 10.1097/MEG.0b013e328335b29e, PubMed 20154627

Dahl TB, Haukeland JW, Yndestad A, Ranheim T, Gladhaug IP, Damås JK, Haaland T, Løberg EM, Arntsen B, Birkeland K, Bjøro K, Ulven SM, Konopski Z, Nebb HI, Aukrust P, Halvorsen B (2010)
Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease
J Clin Endocrinol Metab, 95 (6), 3039-47
DOI 10.1210/jc.2009-2148, PubMed 20392873

Scholz T, Karlsen TH, Sanengen T, Schrumpf E, Line PD, Boberg KM, Jörgensen PF, Fosby B, Bentdal O, Ostensen AB, Osnes S, Riddervold F, Haugaa H, Hausken J, Bergmann JB, Foss S, Björo K, Foss A, Levertransplantasjonsgruppen ved Oslo universitetssykehus, Rikshospitalet (2009)
[Liver transplantation in Norway through 25 years]
Tidsskr Nor Laegeforen, 129 (24), 2587-92
DOI 10.4045/tidsskr.09.1106, PubMed 20029553

Yndestad A, Haukeland JW, Dahl TB, Bjøro K, Gladhaug IP, Berge C, Damås JK, Haaland T, Løberg EM, Linnestad P, Birkeland K, Konopski Z, Halvorsen B, Berge RK, Aukrust P (2009)
A complex role of activin A in non-alcoholic fatty liver disease
Am J Gastroenterol, 104 (9), 2196-205
DOI 10.1038/ajg.2009.318, PubMed 19532130

Haukeland JW, Konopski Z, Eggesbø HB, von Volkmann HL, Raschpichler G, Bjøro K, Haaland T, Løberg EM, Birkeland K (2009)
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial
Scand J Gastroenterol, 44 (7), 853-60
DOI 10.1080/00365520902845268, PubMed 19811343

Dalgard O, Bjøro K, Ring-Larsen H, Bjornsson E, Holberg-Petersen M, Skovlund E, Reichard O, Myrvang B, Sundelöf B, Ritland S, Hellum K, Frydén A, Florholmen J, Verbaan H, North-C Group (2008)
Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
Hepatology, 47 (1), 35-42
DOI 10.1002/hep.21975, PubMed 17975791

Haukeland JW, Lorgen I, Schreiner LT, Frigstad SO, Brandsaeter B, Bjøro K, Bang C, Raknerud N, Konopski Z (2007)
Incidence rates and causes of cirrhosis in a Norwegian population
Scand J Gastroenterol, 42 (12), 1501-8
DOI 10.1080/00365520701478014, PubMed 17852839

Melum E, Friman S, Bjøro K, Rasmussen A, Isoniemi H, Gjertsen H, Bäckman L, Oksanen A, Olausson M, Duraj FF, Ericzon BG (2007)
Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma
J Hepatol, 47 (6), 777-83
DOI 10.1016/j.jhep.2007.06.013, PubMed 17714825

Andriulli A, Dalgard O, Bjøro K, Mangia A (2006)
Short-term treatment duration for HCV-2 and HCV-3 infected patients
Dig Liver Dis, 38 (10), 741-8
DOI 10.1016/j.dld.2006.06.006, PubMed 16916631

Melum E, Schrumpf E, Bjøro K (2006)
Liver TX for hepatitis C cirrhosis in a low prevalence population: risk factors and status at evaluation
Scand J Gastroenterol, 41 (5), 592-6
DOI 10.1080/00365520500347113, PubMed 16638703

Slinning C, Bjøro K, Boberg KM, Schrumpf E (2006)
[Fulminant hepatic failure in malignant liver disease]
Tidsskr Nor Laegeforen, 126 (7), 917-8
PubMed 16554884

Haukeland JW, Damås JK, Konopski Z, Løberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjøro K, Aukrust P (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
J Hepatol, 44 (6), 1167-74
DOI 10.1016/j.jhep.2006.02.011, PubMed 16618517

Haukeland JW, Konopski Z, Linnestad P, Azimy S, Marit Løberg E, Haaland T, Birkeland K, Bjøro K (2005)
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease
Scand J Gastroenterol, 40 (12), 1469-77
DOI 10.1080/00365520500264953, PubMed 16293559

Brandsaeter B, Schrumpf E, Bentdal O, Brabrand K, Smith HJ, Abildgaard A, Clausen OP, Bjoro K (2005)
Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors
Liver Transpl, 11 (11), 1361-9
DOI 10.1002/lt.20444, PubMed 16184522

Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjoro K, Schrumpf E, Nordic Liver Transplantation Grp (2005)
Chernopreventive effect of ursodeoxycholic acid in primary sclerosing cholangitis?
FALK SYMP, 141, 242-249

Dalgard O, Bjøro K, Hellum KB, Myrvang B, Ritland S, Skaug K, Raknerud N, Bell H (2004)
Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study
Hepatology, 40 (6), 1260-5
DOI 10.1002/hep.20467, PubMed 15558712

Brandsaeter B, Schrumpf E, Clausen OP, Abildgaard A, Hafsahl G, Bjøro K (2004)
Recurrent sclerosing cholangitis or ischemic bile duct lesions--a diagnostic challenge?
Liver Transpl, 10 (8), 1073-4
DOI 10.1002/lt.20192, PubMed 15390337

Brandsaeter B, Isoniemi H, Broomé U, Olausson M, Bäckman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K, Mäkisalo H, Kirkegaard P, Friman S, Bjøro K (2004)
Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy
J Hepatol, 40 (5), 815-22
DOI 10.1016/j.jhep.2004.01.002, PubMed 15094230

Brandsaeter B, Friman S, Broomé U, Isoniemi H, Olausson M, Bäckman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K, Mäkisalo H, Kirkegaard P, Bjøro K (2003)
Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries
Scand J Gastroenterol, 38 (11), 1176-83
DOI 10.1080/00365520310006009, PubMed 14686722

Brandsaeter B, Broomé U, Isoniemi H, Friman S, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K, Mäkisalo H, Olsson R, Olausson M, Kirkegaard P, Bjøro K (2003)
Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list
Liver Transpl, 9 (9), 961-9
DOI 10.1053/jlts.2003.50169, PubMed 12942458

Moen EM, Sagedal S, Bjøro K, Degré M, Opstad PK, Grinde B (2003)
Effect of immune modulation on TT virus (TTV) and TTV-like-mini-virus (TLMV) viremia
J Med Virol, 70 (1), 177-82
DOI 10.1002/jmv.10356, PubMed 12629661

Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
Scand J Gastroenterol, 38 (3), 320-7
DOI 10.1080/00365520310000681, PubMed 12737449

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease
Scand J Gastroenterol, 38 (3), 320-327
DOI 10.1080/00365520310000681, PubMed 28248598

Bjøro K, Ericzon BG, Kirkegaard P, Höckerstedt K, Söderdahl G, Olausson M, Foss A, Schmidt LE, Isoniemi H, Brandsaeter B, Friman S (2003)
Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation
Transplantation, 75 (3), 347-53
DOI 10.1097/01.TP.0000044359.72379.E5, PubMed 12589157

Drivenes A, Bjøro K, Holter E, Bentdal Ø, Boberg KM (2003)
[Fulminant liver failure in acute hepatitis B virus infection]
Tidsskr Nor Laegeforen, 123 (2), 172-4
PubMed 12607499

Brandsaeter B, Höckerstedt K, Friman S, Ericzon BG, Kirkegaard P, Isoniemi H, Olausson M, Broome U, Schmidt L, Foss A, Bjøro K (2002)
Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries
Liver Transpl, 8 (11), 1055-62
DOI 10.1053/jlts.2002.35556, PubMed 12424720

Distante S, Bjøro K, Hellum KB, Myrvang B, Berg JP, Skaug K, Raknerud N, Bell H (2002)
Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection
Liver, 22 (3), 269-75
DOI 10.1046/j.0106-9543.2002.01672.x, PubMed 12100578

Dalgard O, Bjøro K, Hellum K, Myrvang B, Bjøro T, Haug E, Bell H (2002)
Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy
J Intern Med, 251 (5), 400-6
DOI 10.1046/j.1365-2796.2002.00974.x, PubMed 11982739

Bell H, Dalgard O, Bjøro K, Hellum KB, Myrvang B (2002)
[Treatment of chronic hepatitis C]
Tidsskr Nor Laegeforen, 122 (9), 926-8
PubMed 12082838

Bjøro K, Bell H, Myrvang B, Skaug K, Raknerud N, Sandvei P, Størseth S, Ritland S, Lund-Tønnesen S, Bucher A, Hellum KB (2002)
Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study
Scand J Gastroenterol, 37 (3), 344-9
DOI 10.1080/003655202317284264, PubMed 11916198

Bjøro K, Bell H, Hellum KB, Skaug K, Raknerud N, Sandvei P, Døskeland B, Maeland A, Lund-Tønnesen S, Myrvang B (2002)
Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study
Scand J Gastroenterol, 37 (2), 226-32
DOI 10.1080/003655202753416920, PubMed 11843062

Dalgard O, Bjøro K, Hellum K, Myrvang B, Skaug K, Gutigard B, Bell H, Construct Group (2002)
Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up
Eur Addict Res, 8 (1), 45-9
DOI 10.1159/000049487, PubMed 11818693

Ericzon BG, Bjoro K, Hoeckerstedt K, Hanssen B, Olausson M, Isoniemi H, Kirkegaard P, Soderdahl G, Foss A, Friman S (2001)
Time to request ABO-identity when transplanting for fulminant hepatic failure?
Transplant Proc, 33 (7-8), 3466-7
DOI 10.1016/s0041-1345(01)02493-9, PubMed 11750483

Bjøro K, Petrova EP, Thomas MG, Frøland SS, Williams R, Naoumov NV (2001)
TT virus infection in patients with primary hypogammaglobulinaemia: natural history and relationship to liver disease in the immunocompromised host
Scand J Gastroenterol, 36 (9), 987-93
DOI 10.1080/003655201750305530, PubMed 11521992

Bjøro K, Kirkegaard P, Ericzon BG, Friman S, Schrumpf E, Isoniemi H, Herlenius G, Olausson M, Rasmussen A, Foss A, Höckerstedt K (2001)
Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?
Transplant Proc, 33 (4), 2511-3
DOI 10.1016/s0041-1345(01)02080-2, PubMed 11406230

Bjøro K, Höckerstedt K, Ericzon BG, Friman S, Hjortrup A, Keiding S, Schrumpf E, Duraj F, Olausson M, Mäkisalo H, Bergan A, Kirkegaard P (2000)
Liver transplantation in patients over 60 years of age
Transpl Int, 13 Suppl 1, S165-70
DOI 10.1007/s001470050315, PubMed 11111989

Bjøro K, Skaug K, Haaland T, Frøland SS (1999)
Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia
QJM, 92 (8), 433-41
DOI 10.1093/qjmed/92.8.433, PubMed 10627859

Bjøro K, Friman S, Höckerstedt K, Kirkegaard P, Keiding S, Schrumpf E, Olausson M, Oksanen A, Isoniemi H, Hjortrup A, Bergan A, Ericzon BG (1999)
Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results
Scand J Gastroenterol, 34 (7), 714-22
DOI 10.1080/003655299750025930, PubMed 10466884

Bjøro K, Haaland T, Skaug K, Frøland SS (1999)
The spectrum of hepatobiliary disease in primary hypogammaglobulinaemia
J Intern Med, 245 (5), 517-24
DOI 10.1046/j.1365-2796.1999.00457.x, PubMed 10363753

Bell H, Hellum K, Harthug S, Myrvang B, Ritland S, Maeland A, von der Lippe B, Bjøro K, Skaug K, Gutigard BG, Raknerud N, Simmonds P (1999)
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group
Scand J Gastroenterol, 34 (2), 194-8
DOI 10.1080/00365529950173087, PubMed 10192200

Bjøro K, Gjerstad L, Bentdal O, Osnes S, Schrumpf E (1998)
Topiramate and fulminant liver failure
Lancet, 352 (9134), 1119
DOI 10.1016/s0140-6736(05)79759-2, PubMed 9798593

Bjøro K, Schrumpf E, Bergan A, Haaland T, Skaug K, Frøland SS (1998)
Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia
Scand J Infect Dis, 30 (5), 520-2
DOI 10.1080/00365549850161575, PubMed 10066058

Keiding S, Høckerstedt K, Bjøro K, Bondesen S, Hjortrup A, Isoniemi H, Erichsen C, Söderdahl G, Ericzon BG (1997)
The Nordic multicenter double-blind randomized controlled trial of prophylactic ursodeoxycholic acid in liver transplant patients
Transplantation, 63 (11), 1591-4
DOI 10.1097/00007890-199706150-00009, PubMed 9197351

Bjøro K, Blomhoff JP, Schrumpf E, Brosstad F, Bergan A, Egge T (1997)
[Hepatic vein thrombosis. Diagnostic and therapeutic difficulties]
Tidsskr Nor Laegeforen, 117 (9), 1274-6
PubMed 9182354

Odeberg J, Yun Z, Sönnerborg A, Bjøro K, Uhlén M, Lundeberg J (1997)
Variation of hepatitis C virus hypervariable region 1 in immunocompromised patients
J Infect Dis, 175 (4), 938-43
DOI 10.1086/513995, PubMed 9086154

Haugen G, Stray-Pedersen S, Bjøro K (1996)
The influence of angiotensin II on prostanoid production in preterm human umbilical arteries
Gynecol Obstet Invest, 42 (3), 159-62
DOI 10.1159/000291936, PubMed 8938465

Bjøro K, Krarup H, Bell H, Christophersen P, Evensen S, Frøland SS, Laursen A, B vd Lippe B, Maeland A, Ranek L (1995)
Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices
Scand J Gastroenterol, 30 (11), 1119-24
DOI 10.3109/00365529509101617, PubMed 8578174

Rokkones E, Fromm SH, Kareem BN, Klungland H, Olstad OK, Hogset A, Iversen J, Bjoro K, Gautvik KM (1995)
Human parathyroid hormone as a secretory peptide in milk of transgenic mice
J Cell Biochem, 59 (2), 168-76
DOI 10.1002/jcb.240590206, PubMed 8904311

Haugen G, Stray-Pedersen S, Bjøro K (1995)
Effect of phenazone (antipyrine) on the prostanoid formation in human umbilical arteries perfused in vitro
Gynecol Obstet Invest, 39 (1), 8-10
DOI 10.1159/000292366, PubMed 7890260

Sanderud J, Oroszlàn G, Bjøro K, Kumlin M, Saugstad OD (1995)
D-penicillamine inhibits the action of reactive oxygen species in the pig pulmonary circulation
J Perinat Med, 23 (5), 385-93
DOI 10.1515/jpme.1995.23.5.385, PubMed 8606345

Bjøro K, Frøland SS, Yun Z, Samdal HH, Haaland T (1994)
Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin
N Engl J Med, 331 (24), 1607-11
DOI 10.1056/NEJM199412153312402, PubMed 7526215

Høie J, Jørgensen OG, Nesland JM, Møller P, Bjøro K (1994)
[Medullary thyroid carcinoma--familial or sporadic disease?]
Tidsskr Nor Laegeforen, 114 (25), 2951-4
PubMed 7974404

Bjoro K, Bjornsborg E, Haraldsen B (1994)
Concerted action on quality
Eur Qual Assur Netw Newsl, 9 (2 Suppl Qa), 8-10
DOI 10.7748/ns.9.2.8.s67, PubMed 7993765

Bjøro K (1993)
[Puerperal infections. From Semmelweis to current problems]
Tidsskr Nor Laegeforen, 113 (30), 3712-4
PubMed 8278957

Rollag H, Thorvaldsen J, Kittelsen P, Bjøro K, Frøland S (1993)
[Hepatitis C virus infections among persons attending special clinics dealing with problems related to social conditions]
Tidsskr Nor Laegeforen, 113 (19), 2397-400
PubMed 7690995

Sanderud J, Bjøro K, Saugstad OD (1993)
Oxygen radicals stimulate thromboxane and prostacyclin synthesis and induce vasoconstriction in pig lungs
Scand J Clin Lab Invest, 53 (5), 447-55
DOI 10.1080/00365519309092539, PubMed 8210966

Bjoro K, Kveseth B (1993)
How Norway is improving nursing quality
Int Nurs Rev, 40 (3), 89-93
PubMed 8330956

Bjoro K (1993)
EuroQuan. Quality questions
Eur Qual Assur Netw Newsl, 7 (27 Suppl QA), 15
PubMed 8489931

Bjoro K, Bjorvell H, Thomann-Schoni M (1993)
EuroQuan. Quality in Europe
Eur Qual Assur Netw Newsl, 7 (27 Suppl QA), 9-10
PubMed 8489934

Petersen PH, Blaabjerg O, Irjala K, Icén A, Bjøro K (1993)
External analytical quality assurance for proteins
Ups J Med Sci, 98 (3), 241-58
DOI 10.3109/03009739309179319, PubMed 7974854

PETERSEN PH, BLAABJERG O, IRJALA K, ICEN A, BJORO K (1993)
A MODEL FOR QUALITY ACHIEVEMENT - THE NORDKEM PROTEIN PROJECT
Scand. J. Clin. Lab. Invest., 53 212, 10-12

Hyltoft Petersen P, Blaabjerg O, Irjala K, Icén A, Bjøro K (1993)
A model for quality achievement--the NORDKEM protein project
Scand J Clin Lab Invest Suppl, 212, 10-2
PubMed 8465144

Bjøro K, Schrumpf E (1992)
[Hepatitis C]
Tidsskr Nor Laegeforen, 112 (29), 3654-5
PubMed 1471122

Bjøro K (1992)
[Norwegian Nurses' Association's project: training in quality assurance]
Fag Tidsskr Sykepleien, 80 (2), 14-6
PubMed 1599777

HAUGEN G, STRAYPEDERSEN S, BJORO K (1992)
THE INFLUENCE OF BRADYKININ ON THE PROSTANOID PRODUCTION IN UMBILICAL ARTERIES IN PREECLAMPSIA
CLIN EXP HYPERTENS B, 11 (2-3), 147-163

Bjøro K (1992)
[Development of standards and quality assurance in nursing services--Norway]
Vard Nord Utveckl Forsk, 12 (3-4), 16-9
DOI 10.1177/010740839201200306, PubMed 1441056

Piene H, Bjoro K (1992)
Concerted action programme on quality assurance in hospitals in Norway
World Hosp, 28 (2), 25-7
PubMed 10121741

Bjøro K (1991)
[Quality in nursing. Project "Quality assurance in nursing services". Status report]
Fag Tidsskr Sykepleien, 79 (8), 14-5, 34
PubMed 1777325

Bjøro K (1991)
[Quality in nursing. Regulation of the profession--an important form of quality assurance]
Fag Tidsskr Sykepleien, 79 (6), 2-6, 31
PubMed 1931335

Haugen G, Bjøro K, Stray-Pedersen S (1991)
The influence of extra-umbilical serotonin, PGE2 and PGF2 alpha on prostanoid production in human umbilical arteries
Scand J Clin Lab Invest, 51 (2), 131-5
DOI 10.3109/00365519109091098, PubMed 2042017

Bjøro K (1991)
[Make quality assurance the order of the day?]
J Sykepleien, 79 (3), 13
PubMed 1859708

Haugen G, Bjøro K, Stray-Pedersen S (1991)
Vasoactive effects of intra- and extravascular serotonin, PGE2 and PGF2 alpha in human umbilical arteries
Gynecol Obstet Invest, 31 (4), 208-12
DOI 10.1159/000293160, PubMed 1885089

Haugen G, Stray-Pedersen S, Bjøro K (1990)
Prostanoid production in umbilical arteries from preterm and term deliveries perfused in vitro
Early Hum Dev, 24 (2), 153-61
DOI 10.1016/0378-3782(90)90144-8, PubMed 2076689

Bjøro K, Vatn M, Schrumpf E, Ganes T, Lundar T, Bergan A (1990)
[Liver transplantation in fulminant hepatic failure]
Tidsskr Nor Laegeforen, 110 (26), 3372-5
PubMed 2256061

Bjøro K, Schrumpf E, Elgjo K, Nordgård K (1990)
[Chronic non-A non-B hepatitis treated with interferon]
Tidsskr Nor Laegeforen, 110 (11), 1346-8
PubMed 2111053

Hyltoft Peterson P, Blaabjerg O, Bjøro K, Icèn A, Irjala K (1990)
The Nordic Protein Project
Ups J Med Sci, 95 (3), 251-5
DOI 10.3109/03009739009178598, PubMed 2100402

HAUGEN G, STRAYPEDERSEN S, BJORO K (1990)
ANGIOTENSIN CONVERTING ENZYME AND ANGIOTENSIN STIMULATED PROSTANOID PRODUCTION IN THE UMBILICAL ARTERY IN PREECLAMPSIA
CLIN EXP HYPERTENS B, 9 (2), 135-150

HAUGEN G, STRAYPEDERSEN S, BJORO K (1990)
VASOACTIVE-INTESTINAL-PEPTIDE AND PROSTANOID PRODUCTION IN NORMAL AND SINGLE UMBILICAL ARTERY CORDS IN NORMOTENSIVE AND HYPERTENSIVE PREGNANCIES
CLIN EXP HYPERTENS B, 9 (1), 69-80

Bjøro K (1989)
[Norwegian Nurses' Association project: quality assurance and development of standards in nursing services]
Fag Tidsskr Sykepleien, 77 (18), 18-9
PubMed 2595535

Bendvold E, Aanesen A, Bjøro K (1988)
[Objective and automated semen analysis. CellSoft-CASA]
Tidsskr Nor Laegeforen, 108 (29), 2495-7
PubMed 3206464

Abyholm T, Henriksen T, Tanbo T, Magnus O, Bjøro K (1988)
[Treatment of infertility]
Tidsskr Nor Laegeforen, 108 (13), 1037-40
PubMed 3291188

BENTDAL OH, FROLAND SS, ASKEVOLD F, BJORO K, LARSEN S (1988)
NUTRITIONAL ASSESSMENT OF ANOREXIA-NERVOSA PATIENTS - ANALYSIS OF ANTHROPOMETRIC AND BIOCHEMICAL VARIABLES TO EVALUATE PATIENTS AT RISK
Clin. Nutr., 7 (2), 93-99

Tanbo T, Abyholm T, Henriksen T, Magnus O, Bjøro K (1988)
[In vitro fertilization]
Tidsskr Nor Laegeforen, 108 (1), 12-4, 7
PubMed 3353896

Abyholm T, Henriksen T, Magnus O, Tanbo T, Bjøro K (1988)
[Gamete intrafallopian transfer in infertility]
Tidsskr Nor Laegeforen, 108 (1), 5-7
PubMed 3281313

Rivrud GN, Moen M, Moe N, Berg K, Bjøro K (1988)
Mutagenicity testing of amniotic fluid from diabetic women, with special reference to their smoking habits
Gynecol Obstet Invest, 26 (2), 113-7
DOI 10.1159/000293681, PubMed 3065159

Oian P, Skråmm I, Hannisdal E, Bjøro K (1988)
Breech delivery. An obstetrical analysis
Acta Obstet Gynecol Scand, 67 (1), 75-9
DOI 10.3109/00016348809004172, PubMed 3176916

Stormorken H, Gjemdal T, Bjøro K (1988)
Lupus anticoagulant: a unique case with lupus anticoagulant and habitual abortion together with antifactor II antibody and bleeding tendency
Gynecol Obstet Invest, 26 (1), 83-8
DOI 10.1159/000293678, PubMed 3139508

Bjøro K, Haugen G, Stray-Pedersen S (1987)
Altered prostanoid formation in human umbilical vasculature in response to variations in oxygen tension
Prostaglandins, 34 (3), 377-84
DOI 10.1016/0090-6980(87)90083-9, PubMed 3432554

Rivrud GN, Berg K, Anderson D, Blowers S, Bjøro K (1986)
Mutagenic effect of amniotic fluid from smoking women at term
Mutat Res, 171 (2-3), 71-7
DOI 10.1016/0165-1218(86)90037-6, PubMed 3528838

Ogaard AR, Bjøro K, Bukholm G, Berdal BP (1986)
Pseudomonas aeruginosa virulence factors: modifications by sub-inhibitory concentrations of carbenicillin or gentamicin
Acta Pathol Microbiol Immunol Scand B, 94 (2), 63-8
DOI 10.1111/j.1699-0463.1986.tb03021.x, PubMed 3088910

Bjøro K, Hovig T, Stokke KT, Stray-Pedersen S (1986)
Formation of prostanoids in human umbilical vessels perfused in vitro
Prostaglandins, 31 (4), 683-98
DOI 10.1016/0090-6980(86)90174-7, PubMed 3523623

Bjøro K (1986)
Prostacyclin and thromboxane formation in human umbilical arteries following stimulation with vasoactive autacoids
Prostaglandins, 31 (4), 699-714
DOI 10.1016/0090-6980(86)90175-9, PubMed 3523624

Bjøro K, Stray-Pedersen S (1986)
Effects of vasoactive autacoids on different segments of human umbilicoplacental vessels
Gynecol Obstet Invest, 22 (1), 1-6
DOI 10.1159/000298881, PubMed 2875016

Bjøro K, Stray-Pedersen S (1986)
Characterization of the responses to serotonin and prostanoids in human umbilical arteries perfused in vitro
Scand J Clin Lab Invest Suppl, 184, 85-90
PubMed 3155351

Bjøro K, Stokke KT, Stray-Pedersen S (1986)
Altered angiotensin-prostanoid interactions in umbilical arteries in pregnancy-induced hypertension
Scand J Clin Lab Invest Suppl, 184, 91-6
PubMed 3473616

BJORO K, STRAYPEDERSEN S (1986)
CHARACTERIZATION OF THE RESPONSES TO SEROTONIN AND PROSTANOIDS IN HUMAN UMBILICAL ARTERIES PERFUSED INVITRO
Scand. J. Clin. Lab. Invest., 46 184, 85-90

Rivrud GN, Berg K, Anderson D, Blowers S, Bjøro K (1986)
Study of the amniotic fluid from smokers and non-smokers in the Ames test
Mutat Res, 169 (1-2), 11-6
DOI 10.1016/0165-1218(86)90011-x, PubMed 3511362

Bjøro K, Stray-Pedersen S (1986)
In vitro perfusion studies on human umbilical arteries. II. Effects of prostacyclin and a thromboxane A2 mimetic
Acta Obstet Gynecol Scand, 65 (5), 467-71
DOI 10.3109/00016348609157387, PubMed 3535361

BJORO K, STOKKE KT, STRAYPEDERSEN S (1986)
ALTERED ANGIOTENSIN-PROSTANOID INTERACTIONS IN UMBILICAL ARTERIES IN PREGNANCY-INDUCED HYPERTENSION
Scand. J. Clin. Lab. Invest., 46 184, 91-96

Bjøro K, Stray-Pedersen S (1986)
In vitro perfusion studies on human umbilical arteries. I. Vasoactive effects of serotonin, PGF2 alpha and PGE2
Acta Obstet Gynecol Scand, 65 (4), 351-5
DOI 10.3109/00016348609157359, PubMed 3461666

Bjøro K (1985)
Effects of angiotensin I and II and their interactions with some prostanoids in perfused human umbilical arteries
Prostaglandins, 30 (6), 989-98
DOI 10.1016/0090-6980(85)90171-6, PubMed 3911295

Abyholm T, Holst N, Bjoro K (1985)
Pregnancy rates after tubal surgery in different etiological groups of infertility
Acta Eur Fertil, 16 (6), 405-9
PubMed 3832710

Ogaard AR, Bjøro K, Bukholm G, Berdal BP (1985)
Correlation between adhesion of Pseudomonas aeruginosa bacteria to cell surfaces and the presence of some factors related to virulence
Acta Pathol Microbiol Immunol Scand B, 93 (3), 211-6
DOI 10.1111/j.1699-0463.1985.tb02878.x, PubMed 3929559

Berdal BP, Bjøro K, Bukholm G, Ogaard AR (1985)
Pressure- and temperature-dependent adhesion of Pseudomonas aeruginosa to HEp-2 cells
Acta Pathol Microbiol Immunol Scand B, 93 (2), 157-8
DOI 10.1111/j.1699-0463.1985.tb02868.x, PubMed 3925713

Björo K, Björo K (1985)
Disturbed intrauterine growth in twins: etiological aspects
Acta Genet Med Gemellol (Roma), 34 (1-2), 73-9
DOI 10.1017/s0001566000004943, PubMed 4050298

Bjøro K, Myhre E (1984)
The role of chronic non-specific inflammatory lesions of the placenta in intra-uterine growth retardation
Acta Pathol Microbiol Immunol Scand A, 92 (2), 133-7
DOI 10.1111/j.1699-0463.1984.tb04387.x, PubMed 6702461

Bjøro K, Dybvik T (1984)
[Testicular retention. Age at diagnosis and surgical correction at a county hospital]
Tidsskr Nor Laegeforen, 104 (1), 14-6
PubMed 6141647

Holst N, Abyholm T, Bjøro K (1983)
[Surgical treatment of tubal infertility]
Tidsskr Nor Laegeforen, 103 (31), 2106-8
PubMed 6658734

Bjøro K (1983)
Vascular anomalies of the umbilical cord. II. Perinatal and pediatric implications
Early Hum Dev, 8 (3-4), 279-87
DOI 10.1016/0378-3782(83)90010-5, PubMed 6685618

Bjøro K (1983)
Vascular anomalies of the umbilical cord: I. Obstetric implications
Early Hum Dev, 8 (2), 119-27
DOI 10.1016/0378-3782(83)90067-1, PubMed 6884254

Molne K, Abyholm T, Bjøro K (1983)
[A model for evaluation of infertility. Pregnancy rate after 6 years observation]
Tidsskr Nor Laegeforen, 103 (7), 663-6
PubMed 6868042

Bjøro K, Dybvik T (1983)
Congenital abnormalities and growth patterns among cryptorchidic boys
Ann Chir Gynaecol, 72 (6), 342-6
PubMed 6141761

Bjøro K, Molne K, Skjaeraasen J, Berg K, van der Hagen CB, Kobro G (1981)
[Prenatal diagnosis. A clinical report]
Tidsskr Nor Laegeforen, 101 (33), 1896-8
PubMed 7339978

Rossavik IK, Bjøro K (1981)
The prenatal determination of fetal weight by dynamic scanning
Early Hum Dev, 5 (2), 133-8
DOI 10.1016/0378-3782(81)90044-x, PubMed 7249993

Bjøro K (1981)
Gross pathology of the placenta in intrauterine growth retardation
Ann Chir Gynaecol, 70 (6), 316-22
PubMed 7337404

Bjøro K (1979)
[Meno-metrorrhagia. Differential diagnosis and treatment]
Tidsskr Nor Laegeforen, 99 (13), 648-51
PubMed 451969

Berg K, Bjoro K (1975)
[Editorial: Prenatal diagnosis of hereditary diseases]
Tidsskr Nor Laegeforen, 95 (2), 123-5
PubMed 123095

Bjoro K (1973)
[Primary amenorrhea]
Tidsskr Nor Laegeforen, 93 (14), 1028-31
PubMed 4755946

van der Hagen CB, Borresen AL, Molne K, Oftedal G, Bjoro K, Berg K (1973)
Metachromatic leukodystrophy. I. Prenatal detection of arylsulphatase A deficiency
Clin Genet, 4 (3), 256-9
PubMed 4765208

Bjoro K (1972)
[Oestrogen metabolism in pregnant women]
Tidsskr Nor Laegeforen, 92 (29), 1926-8
PubMed 4264097

Bjoro K (1972)
[Etiology and diagnosis of retarded intrauterine fetal growth and threatening fetal death]
Tidsskr Nor Laegeforen, 92 (29), 1919-22
PubMed 4635664

Vangen O, Molne K, Bjoro K (1972)
[Diabetes mellitus and pregnancy. Perinatal mortality in the Rikshospitalet, Women's department, 1950-1970]
Tidsskr Nor Laegeforen, 92 (19), 1313-7
PubMed 4559766

Bjoro K (1972)
Oestriol assay in obstetric practice
Acta Endocrinol Suppl (Copenh), 161, 3-47
PubMed 4537326

Bjoro K (1971)
[Thyroid function in women with functional ovarian failure]
Tidsskr Nor Laegeforen, 91 (25), 1804-8
PubMed 5165008

Bjoro K, Bugge S, Norman N (1971)
Urinary excretion of oestriol in normal pregnancy. The effect of some variations in hydrolysis and extraction
J Oslo City Hosp, 21 (2), 13-25
PubMed 5552887

Bjoro K (1970)
[The activity of the uterine muscle in pregnancy and delivery]
Tidsskr Nor Laegeforen, 90 (23), 2205-7
PubMed 5481867

Bjoro K (1970)
[Patients with female phenotype and male chromosome pattern. Clinical classification and treatment]
Tidsskr Nor Laegeforen, 90 (2), 80-6
PubMed 5465369

Bjoro K (1969)
[Hormonal contraception. Mechanism of effect and usefulness]
Tidsskr Nor Laegeforen, 89 (18), 1426-30
PubMed 5376304

Myhre E, Bjoro K (1969)
Oral contraceptives and cervical cancer. A preliminary report of an experimental study
Acta Pathol Microbiol Scand, 76 (3), 495-6
PubMed 5823365

Bjoro K (1967)
[The immunological role of the placenta]
Tidsskr Nor Laegeforen, 87 (18), Suppl:1546-9
PubMed 5590434

Kvarstein B, Bjoro K (1967)
[Histochemical changes in the endometrium after administration of the progestogen quingestanol]
Nord Med, 77 (11), 341-2
PubMed 6020763

Kluge T, Skyberg D, Bjoro K (1967)
Fatal herpes simplex infection in the newborn. Caesarean section as a prophylactic measure
Acta Obstet Gynecol Scand, 46 (3), 369-77
DOI 10.3109/00016346709158640, PubMed 4169353

Bjoro K (1966)
[Regulating mechanisms of ovarian function, with special reference to the role of the uterus]
Tidsskr Nor Laegeforen, 86 (24), 1704-10
PubMed 5980413

Björo K (1966)
Amenorrhoea. A study with particular attention to the problems of ovarian failure
Acta Obstet Gynecol Scand, 45 (S1), 68-124
DOI 10.3109/00016346609158469, PubMed 5936129

BJORO K (1965)
[POLYCYSTIC OVARIES AND INFERTILITY]
Tidsskr Nor Laegeforen, 85, 317-25
PubMed 14311451

Bjoro K (1965)
Primary amenorrhoea. A study with special reference to the morphology of the genital organs
Acta Obstet Gynecol Scand, 44 (S4), 3-126
PubMed 5861985

STRAND A, BJORO K (1962)
[Examination of semen]
Tidsskr Nor Laegeforen, 82, 290-2
PubMed 13917612

BJORO K (1962)
Secondary oligo-amenorrhoea; a clinical and endocrinological evaluation
Acta Obstet Gynecol Scand Suppl, 41(Suppl 6), 1-47
DOI 10.3109/00016346209157178, PubMed 13971338

BJORO K (1961)
[Secondary amenorrhea. Hormone administration as a diagnostic aid]
Tidsskr Nor Laegeforen, 81, 1151-4
PubMed 13869631

BJORO K, IVERSEN S (1959)
[Congenital malformations in the light of obstetrical material]
Tidsskr Nor Laegeforen, 79, 1308-12
PubMed 13801127

BJORO K (1959)
[Placenta percreta with spontaneous rupture of the uterus]
Nord Med, 62, 1296-7
PubMed 13801128

BJORO K, MEJLAENDER O (1958)
[Urinary incontinence in women; report on cases treated with modified Kelly plastic surgery]
Tidsskr Nor Laegeforen, 78 (9), 414-9
PubMed 13569432

BJORO K (1958)
[Use of vaginal cytology to determine the date of delivery]
Tidsskr Nor Laegeforen, 78 (8), 349-52
PubMed 13556749

AMUNDSEN E, BJORO K (1957)
[Not Available]
Nord Med, 58 (47), 1819-21
PubMed 13493860

BJORO K (1957)
[Parasitic twins; a case of acardius amorphus]
Tidsskr Nor Laegeforen, 77 (8), 344-6
PubMed 13433700

BJORO K, MYLIUS E (1957)
Thecoma of the ovary and hyperplasia of the uterus with a picture like an adenoacanthoma; a case report
Acta Pathol Microbiol Scand, 40 (6), 470-4
PubMed 13457891

BJORO K (1956)
[Ectopic pregnancy; a follow-up study]
Tidsskr Nor Laegeforen, 76 (15), 518-21
PubMed 13380819

BJORO K (1956)
[Not Available]
Tidsskr Nor Laegeforen, 76 (13-14), 479-80; passim
PubMed 13352350

BJORO K (1956)
Shelf operation in the treatment of congenital dysplasia and subluxation of the hip-joint in adults; with special reference to the prevention of secondary osteoarthritis
Acta Orthop Scand, 25 (3), 190-206
PubMed 13326363

BJORO K (1953)
[Mediastinal and subcutaneous emphysema in labor]
Tidsskr Nor Laegeforen, 73 (18), 699-701
PubMed 13102497

Review articles

Bjøro K, Brandsaeter B, Foss A, Schrumpf E (2006)
Liver transplantation in primary sclerosing cholangitis
Semin Liver Dis, 26 (1), 69-79
DOI 10.1055/s-2006-933565, PubMed 16496235

Bjøro K, Schrumpf E (2004)
Liver transplantation for primary sclerosing cholangitis
J Hepatol, 40 (4), 570-7
DOI 10.1016/j.jhep.2004.01.021, PubMed 15030971

Søreide O, Husberg B, Bjøro K, Schrumpf E (1999)
[Liver transplantation--development and experiences]
Tidsskr Nor Laegeforen, 119 (22), 3310-4
PubMed 10533415

Schrumpf E, Bjøro K, Bell H, Harthug S, Hellum KB, Myrvang B, Maeland A, Ritland S (1996)
[Treatment of hepatitis C]
Tidsskr Nor Laegeforen, 116 (15), 1792-4
PubMed 8693463

Bjøro K, Schrumpf E, Bergan A, Flatmark A, Mathisen O, Sødal G, Søreide O, Sanengen T, Innes R, Osnes S (1996)
[Liver transplantation in Norway. Results after 10 years and 114 transplantations]
Tidsskr Nor Laegeforen, 116 (1), 19-24
PubMed 8553329

Molne K, Bjoro K (1977)
[Hormone treatment during the climacteric]
Tidsskr Nor Laegeforen, 97 (2), 89-93
PubMed 319558

Bjoro K (1973)
[Testicular feminization]
Tidsskr Nor Laegeforen, 93 (14), 1040-2
PubMed 4585564

Bjoro K, Kolstad P, Rygh O (1966)
[Oral contraceptives in the limelight. A review and evaluation]
Tidsskr Nor Laegeforen, 86 (24), 1698-704
PubMed 5342602

Other articles

Jørgensen SF, Macpherson ME, Bjøro K, Karlsen TH, Reims HM, Grzyb K, Fosby B, Fevang B, Aukrust P, Nordøy I (2016)
Liver transplantation in patients with primary antibody deficiency
J Allergy Clin Immunol, 139 (5), 1708-1710.e2
DOI 10.1016/j.jaci.2016.10.025, PubMed 27931972

Bjøro K, Aabakken L, Waldum HL (2013)
Cinical gastroenterology
Scand J Gastroenterol, 48 (1), 3
DOI 10.3109/00365521.2013.754638, PubMed 23244450

Bjoro K (2010)
This month in Scandinavian Journal of Gastroenterology
Scand. J. Gastroenterol., 45 (6), 643-644

Bjoro K (2008)
This month in Scandinavian Journal of Gastroenterology
Scand. J. Gastroenterol., 43 (6), 643-644

Haukeland JW, Bjøro K (2007)
[When the brain fails in liver failure]
Tidsskr Nor Laegeforen, 127 (11), 1490
PubMed 17551548

Bjøro K (1997)
[Clinical nursing--pressure sores in 33,000 hospital patients. Interview by Kjell Arne Bakke]
Tidsskr Sykepl, 85 (8), 10-7
PubMed 9470782

BJORO K, FROLAND SS (1995)
HEPATITIS-C AND IMMUNE GLOBULIN - REPLY
N. Engl. J. Med., 332 (18), 1236

Bjøro K, Schrumpf E, Elgjo K, Kolmanskog F (1995)
Monstrous ascites in hereditary haemorrhagic telangiectasia
Scand J Gastroenterol, 30 (1), 92-4
DOI 10.3109/00365529509093242, PubMed 7701258

Bjoro K (1991)
Norwegian nurses focus on quality
Nurs Stand, 6 (2 Suppl PPL), 12-3
DOI 10.7748/ns.6.2.12.s77, PubMed 1685669

BERDAL BP, BJORO K, BUKHOLM G, OGAARD AR (1985)
PRESSURE-DEPENDENT AND TEMPERATURE-DEPENDENT ADHESION OF PSEUDOMONAS-AERUGINOSA TO HEP-2 CELLS
ACTA PATH MICRO IM B, 93 (2), 157-158

Books

Rikshospitalet, Aabakken L, Bjøro K (2004)
Metodebok for leger, Medisinsk avdeling
Medisinsk avdeling, Rikshospitalet, [Oslo] (Utg. 2), 152 s.
BIBSYS 050477226

Bjøro K, Rose-Neil W, Marks I (1994)
Alt om svangerskapet: mor og barn uke for uke fra befruktning til fødsel
Schibsted, Oslo (4. rev. oppl.), 206 s.
BIBSYS 940192055, ISBN 82-516-1512-7

Bjøro K (1986)
Alt om svangerskapet: mor og barn uke for uke fra befruktning til fødsel
Schibsted, Oslo, 214 s.
BIBSYS 864046456, ISBN 82-516-1048-6

Björo K, Bjøro K (1983)
Barnløshet: årsaker og mulige behandlingsmetoder
Tiden, [Oslo], 94 s.
BIBSYS 835009866, ISBN 82-10-02421-3

Madders J, Bjøro K (1982)
Stress og avspenning: hvordan du selv kan bekjempe stress og unngå nervøs spenning, mavesår, søvnløshet, migrene og høyt blodtrykk
Schibsted, Oslo, S.[3]-121
BIBSYS 832006904, ISBN 82-516-0853-8

Ree T, Bjøro K (1979)
Kompendium i karbohydrater
Institutt for medisinsk biokjemi, Oslo (2. utg.), 34 bl.
BIBSYS 950464597

Book chapters

Dalgard O, Bjøro K, Hellum KB, Myrvang B, Ritland S, Skaug K, Raknerud N, Bell H (2004)
Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study
In Hepatology, Wiley, New York, 40(2004)6, S. 1260-5
BIBSYS 051781174

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 38(2003)3, s.320-7
BIBSYS 041707508

Dalgard O, Skaug K, Ritland S, Myrvang B, Hellum K, Bjøro K, Bell H (2003)
Short treatment (14 weeks) with pegylated interferon alpha-2B and ribavirin for the treatment of hepatitis C genotype 2/3 infection
In Journal of hepatology, Munksgaard, København, 38(2003)Suppl 2, s.134-5
BIBSYS 041707680

Bjøro K, Bell H, Hellum K, Skaug K, Raknerud N, Sandvei P, Døskeland B, Mæland A, Lund-Tønnesen S, Myrvang B (2002)
Effect of combined interferon-alpha induction therapy andribavirin on chronic hepatitis C virus infection: a randomized multicentre study
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 37(2002)nr 2, s. 226-232
BIBSYS 031205933

Dalgard O, Bjøro K, Hellum K, Myrvang B, Bjøro T, Haug E, Bell H (2002)
Thyroid dysfunction during treatment of chronic hepatitisC with interferon alpha: no association with wither dosage or efficacy of therapy
In Journal of internal medicine, Blackwell Scientific Publ., Oxford, 251(2002)nr 5, s. 400-406
BIBSYS 031206328

Dalgard O, Bjøro K, Hellum K, Bell H (2002)
Behandling ved kronisk hepatitt C
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 122(2002)nr. 9, S. 926-8
BIBSYS 031200362

Dalgard O, Bjøro K, Hellum K, Myrvang B, Skaug K, Gutigard B, Bell H (2002)
Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up
In European addiction research, Karger, Basel, 8(2002)nr 1, s. 45-49
BIBSYS 031206530

Bjøro K, Bell H, Myrvang B, Skaug K, Raknerud N, Sandvei P, Storseth S, Ritland S, Lund-Tønnesen S, Bucher A, Hellum K (2002)
Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 37(2002)nr 3, s. 344-349
BIBSYS 03120550x

Distante S, Bjøro K, Hellum K, Myrvang B, Berg JP, Skaug K, Raknerud N, Bell H (2002)
Raised serum ferritin predicts non-response to interferonand ribavirin treatment in patients with chronic hepatitis C-infection
In Journal of hepatology, Munksgaard, København, 36(2002)Suppl 1, s. 233
BIBSYS 03142631x

Dalgard O, Bjøro K, Myrvang B, Hellum K, Skaug K, Gutigard B, Bell H (2000)
Long-term follow-up after treatment of chronic hepatitis C with interferon-A: Reinfection in injecting drug users
In Hepatology, Wiley, New York, 32(2000)nr 4 del 2, s.359A
BIBSYS 01080109x

Bjøro K, Bell H, Hellum K, Myrvang B, Skaug K (2000)
Randomized trial of IFN-A induction and ribavirin vs standard IFN-A and ribavirin for chronic HCV in perviously untreated patients
In Hepatology, Wiley, New York, 32(2000)nr 4 del 2, s.317A
BIBSYS 010838090

Theses

Bjøro K (1986)
Vasoactive substances and umbilicoplacental circulation: in vitro perfusion studies on human umbilical vessels
Department of Obstetrics and Gynaecology, Institute of Clinical Biochemistry, National Hospital, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 862138906, ISBN 82-991470-1-8

Page visits: 8079